Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.17 +0.04 (+1.91%)
As of: Oct 2, 2026 · 9:39 AM EDT

Xtl Biopharmaceuticals (XTLB) Shares Outstanding (Diluted) (2011 - 2025)

Updated

Xtl Biopharmaceuticals (XTLB) reported Shares Outstanding (Diluted) of 896.17 million for the quarter ended Dec 31, 2025, up 409.1% from 176.04 million a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Shares Outstanding (Diluted) (2011 - 2025) Analysis & Trends

Dating back to the quarter ended Dec 31, 2011, Xtl Biopharmaceuticals' Shares Outstanding (Diluted) record includes 55 quarters.

  • Shares Outstanding (Diluted) has a five-year compound annual growth rate of 47.5% (years ended Dec 2020 to Dec 2025).
  • By year, Shares Outstanding (Diluted) came in at 176.04 million in the year ended Dec 31, 2024 (+29.2%), 136.23 million in the year ended Dec 31, 2023 (unchanged), 136.23 million in the year ended Dec 31, 2022 (-11.5%) and 153.89 million in the year ended Dec 31, 2021 (+19.7%).
  • The figure for the quarter ended Dec 31, 2025 ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to the quarter ended Dec 31, 2011.
  • Year over year, Shares Outstanding (Diluted) gained in three of the last six quarters, with growth averaging 77.9%.
  • The high point for year-over-year Shares Outstanding (Diluted) in five years was the quarter ended Dec 31, 2025 (growth of 409.1%); the low point was the quarter ended Dec 31, 2022 (a decline of 11.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Xtl Biopharmaceuticals 2.27 Bn 2.27 Bn - 896.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 896.17 Mn
Jun 30, 2025 176.04 Mn
Dec 31, 2024 176.04 Mn
Sep 30, 2024 136.23 Mn
Jun 30, 2024 136.23 Mn
Mar 31, 2024 136.23 Mn
Dec 31, 2023 136.23 Mn
Sep 30, 2023 136.23 Mn
Jun 30, 2023 136.23 Mn
Mar 31, 2023 136.23 Mn
Dec 31, 2022 136.23 Mn
Sep 30, 2022 153.89 Mn
Jun 30, 2022 153.89 Mn
Mar 31, 2022 153.89 Mn
Dec 31, 2021 153.89 Mn
Sep 30, 2021 128.55 Mn
Jun 30, 2021 128.55 Mn
Mar 31, 2021 128.55 Mn
Dec 31, 2020 128.55 Mn
Sep 30, 2020 128.55 Mn
API Access

Xtl Biopharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=XTLB&period=max&api_key=YOUR_API_KEY